XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2

Description of Business, Basis of Presentation and Significant Accounting Policies (Tables)

6 Months Ended

May 31, 2020

Accounting Policies [Abstract]

Schedule of Assets and Liabilities From Contracts With Customers

The following table provides information about assets and liabilities from contracts with customers:

		May 31, 2020				At Adoption
Deposits and other assets		$	433,875			$	329,231
Accounts receivables		$	5,974,457			$	5,867,335
Short-term contract liabilities (deferred revenue)		$	8,839,718			$	8,365,284
Long-term contract liabilities (deferred revenue)		$	25,312,382			$	20,317,231

The Company, in general, requires the customer to pay for processing and storage services at the time of processing. Contract assets include deferred contract acquisition costs, which will be amortized along with the associated revenue. Contract liabilities include payments received in advance of performance under the contract and are realized with the associated revenue recognized under the contract. Accounts receivable consists of amounts due from clients that have enrolled and processed in the umbilical cord blood stem cell processing and storage programs related to renewals of annual plans and amounts due from license affiliates, and sublicensee territories. The Company did not have asset impairment charges related to contract assets in the three and six months ended May 31, 2020 and May 31, 2019.

The following table presents changes in the Company’s contract assets and liabilities during the six months ended May 31, 2020:

		Balance at December 1, 2019				Additions				Deductions				Balance at May 31, 2020
Contract assets (deferred sales commissions)		$	398,535			$	45,801			$	(10,461	)		$	433,875
Accounts receivables		$	6,097,331			$	17,585,653			$	(17,708,527	)		$	5,974,457
Contract liabilities (deferred revenue)		$	32,508,511			$	8,703,442			$	(7,059,853	)		$	34,152,100

The following table presents changes in the Company’s contract assets and liabilities during the six months ended May 31, 2019:

		Balance at December 1, 2018				Additions				Deductions				Balance at May 31, 2019
Contract assets (sales commissions)		$	329,231			$	44,488			$	(8,633	)		$	365,086
Accounts receivables		$	5,867,335			$	18,471,851			$	(18,580,513	)		$	5,758,673
Contract liabilities (deferred revenue)		$	28,682,515			$	9,249,051			$	(7,430,956	)		$	30,500,610

Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table summarizes the financial assets and liabilities measured at fair value on a recurring basis as of May 31, 2020 and November 30, 2019, respectively, segregated among the appropriate levels within the fair value hierarchy:

						Fair Value Measurements
		Fair Value at				at May 31, 2020 Using
Description		May 31, 2020				Level 1				Level 2				Level 3
Assets:
Marketable securities		$	905,429			$	905,429				—				—
Total		$	905,429			$	905,429				—				—
Liabilities:
Contingent consideration		$	3,471,068			$	—				—			$	3,471,068
Total		$	3,471,068			$	—				—			$	3,471,068
Contingent Consideration:
Beginning Balance as of November 30, 2019		$	3,495,057
Subtractions – Cord:Use earnout			—
Fair value adjustment as of May 31, 2020			(23,989	)
Ending balance as of May 31, 2020		$	3,471,068

						Fair Value Measurements
		Fair Value at				at November 30, 2019 Using
Description		November 30, 2019				Level 1				Level 2				Level 3
Assets:
Trading Securities		$	904,053			$	904,053				—				—
		$	904,053			$	904,053				—				—
Liabilities:
Contingent consideration		$	3,495,057			$	—				—			$	3,495,057
Total		$	3,495,057			$	—				—			$	3,495,057

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of contract balances and changes in contract balances.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration